BY

Byline is a well-run state commercial bank executing a consistent playbook: net income has climbed four straight years ($88M→$108M→$121M→$130M) and FY2025 grew 7.7%, while diluted EPS reached $2.89 (+5.1%). Capital is being built the right way — stockholders' equity rose 16.2% to $1.27B and retained earnings jumped 20.9% to $646M, against a 6.61x liabilities/equity ratio that is unremarkable for a bank. Management is also returning capital, with $18.2M of dividends (+14.6%) and $23.7M of buybacks, yet shares outstanding still crept up 2.0%, muting per-share compounding. At $37.61 the stock trades at 13.0x earnings and ~1.35x book (book value ≈ $27.85/share), a full-but-fair multiple for a bank earning a 10.3% ROE.

The quality knock is that 10.3% ROE is only middling — a clean, growing franchise but not a high-return one — and EPS growth (+5.1%) trails net income growth because of share creep. The 73.5% drop in cash to $149M and the 19.9% decline in operating cash flow are line items that look alarming in isolation but are largely noise in a $9.65B-asset bank where balance-sheet mix, not cash, drives earnings; total assets were roughly flat (+1.6%). Nothing here suggests deterioration, but nothing argues for paying up either.